This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,688.86 and a period of performance ending on January 22, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $1,865.62. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,024.80 and runs through December 10, 2024. This is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract has a ceiling value of $1,314.20 and a completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 180 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a ceiling value of $4,436.80 and a completion date of December 3, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication in 180 ml doses to the Defense Logistics Agency (DLA). The contract, valued at $1,270.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract has a completion date of June 20, 2024 and is a firm-fixed price delivery order. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 25, 2022, with a ceiling value of $9,010.98 and a completion date of February 28, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent...
This federal contract award, valued at $3,966.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This contract supports the supply of a diverse range...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a ceiling value of $1,715.06 and a completion date of February 4, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,172.71 Firm Fixed Price Delivery Order is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has an ultimate completion date of July 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999...